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Abstract
Background: Influenza-like illness (ILI) may be caused by a variety of pathogens. Clinical observations are of little help to
recognise myxovirus infection and implement appropriate prevention measures. The limited use of molecular tools
underestimates the role of other common pathogens.
Objectives: During the early weeks of the 2009–2010 flu pandemic, a clinical and virological survey was conducted in adult
and paediatric patients with ILI referred to two French University hospitals in Paris and Tours. Aims were to investigate the
different pathogens involved in ILI and describe the associated symptoms.
Methods: H1N1v pandemic influenza diagnosis was performed with real time RT-PCR assay. Other viral aetiologies were
investigated by the molecular multiplex assay RespiFinder19H. Clinical data were collected prospectively by physicians using
a standard questionnaire.
Results: From week 35 to 44, endonasal swabs were collected in 413 patients. Overall, 68 samples (16.5%) were positive for
H1N1v. In 13 of them, other respiratory pathogens were also detected. Among H1N1v negative samples, 213 (61.9%) were
positive for various respiratory agents, 190 in single infections and 23 in mixed infections. The most prevalent viruses in
H1N1v negative single infections were rhinovirus (62.6%), followed by parainfluenza viruses (24.2%) and adenovirus (5.3%).
70.6% of H1N1v cases were identified in patients under 40 years and none after 65 years. There was no difference between
clinical symptoms observed in patients infected with H1N1v or with other pathogens.
Conclusion: Our results highlight the high frequency of non-influenza viruses involved in ILI during the pre-epidemic period
of a flu alert and the lack of specific clinical signs associated with influenza infections. Rapid diagnostic screening of a large
panel of respiratory pathogens may be critical to define and survey the epidemic situation and to provide critical
information for patient management.
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Introduction
In order to monitor the spread of influenza and alert health
handlers, several epidemiological tools have been developed.
In France, a network of 1300 general practitioners, ‘‘Re ´seau
Sentinelles’’, working throughout the country, provides real-time
clinical data used to evaluate regional and national influenza
spreading [1,2]. The criteria used by this network to define clinical
influenza-like illness (ILI) are the occurrence of a sudden fever
above 39uC with myalgia and respiratory signs. In general no
formal viral diagnosis is carried out. The Groupes Re ´gionaux
d’Observation de la Grippe (GROG) is a second French network
that surveys the emergence and the spread of the influenza viruses
[3,4]. This network is based on clinical surveillance of acute
respiratory infections and laboratory analysis of nasal specimens
collected from adults and children by volunteer general practi-
tioners and pediatricians.
According to the sentinel network’s criteria, French health
authorities proclaimed that flu epidemic level was reached during
the second week of September 2009 (week 37) [5,6]. On the
contrary, data provided by the GROG showed only sporadic
H1N1v activity until the last week of October (week 44) [6,7].
Thus, it became rapidly obvious that a variety of viruses were
circulating in the community and that an overestimation of
myxovirus infection was at stake [8,9,10,11].
As a better knowledge of the epidemic status was a key feature
for national healthcare organization, hospital preparedness,
patient management and disease control, unambiguous viral
PLoS ONE | www.plosone.org 1 August 2011 | Volume 6 | Issue 8 | e23514diagnosis appeared critical. In France, data on viral aetiologies
associated with ILI were at best sporadic and correlations with
clinical symptoms were often lacking. Extensive molecular assays
to screening for respiratory viruses were not available countrywide
for routine diagnosis. Therefore the epidemiological pattern of
respiratory pathogens with overlapping seasonality was poorly
known.
The aim of the present study was to investigate respiratory
pathogens involved in ILI during the early weeks of the 2009–2010
H1N1v diffusion in France (weeks 35 through 44) and describe the
associated symptoms in paediatric and adult populations.
Materials and Methods
Ethics Statement
This study was a non-interventional study with no addition to
usual proceedures. Biological material and clinical data were
obtained only for standard viral diagnostic following physicians’
prescriptions (no specific sampling, no modification of the sampling
protocol, no supplementary question in the national standardized
questionnaire).Data analyseswerecarried outusing an anonymized
database. According to the French Health Public Law (CSP Art L
1121-1.1), such protocol does not require approval of an ethics
committee and is exempted from informed consent application.
Patients and samples
In the two academic hospitals, Saint-Louis hospital (SLS) in Paris
and Tours hospital (TRS), influenza-like illness (ILI) was defined as
a patient suffering from at least one general symptom (fever above
38uC, asthenia, myalgia, shivers or headache) and one respiratory
symptom (cough, dyspnoea, rhinitis or pharyngitis), in agreement
with the guidelines from the French Institut de Veille Sanitaire
(InVS), a governmental institution responsible for surveillance and
alert in all domains of public health [12]. Criteria for severe clinical
presentation were temperature below 35uC or above 39uC despite
antipyretic, cardiac frequency above 120/min, respiratory frequen-
cy above 30/min, respiratory distress, systolic arterial pressure
below 90 mmHg or altered consciousness. Predisposing factors of
critical illness were children younger than one year old, pregnant
women, diabetes, chronic pre-existing disease (such as respiratory,
cardiovascular, neurologic, renal, hepatic or hematologic diseases)
and immunosuppression (associated with HIV infection, organ or
hematopoietic stem cells transplantation, receipt of chemotherapy
or corticosteroids) [13,14]. A cluster of suspected influenza
infections was defined as at least three possible cases in a week in
a closed community (household, school,…) [15].
Inthetwoinstitutions,theprescriptionofH1N1vmoleculartesting
was recommended for patients with ILI and with either a severe
clinical presentation, an underlying risk factor of complications or a
condition which was not improving under antiviral treatment.
Investigation of grouped suspected cases was also recommended.
From week 35 (last week of August) to 44 (last week of October), 413
endonasal swabs were collected in 3 ml of Universal Transport
Medium (Copan Diagnostics Inc, Murrieta, CA) from adults and
children seen in emergency rooms for suspected ILI (Table 1) and
sent to SLS and TRS laboratories for H1N1v detection. The two
microbiology laboratories participated in the reference laboratories
network for the detection of pandemic influenza H1N1v.
Clinical data were collected at the time of medical attention and
reported by clinicians on a national standardized questionnaire
provided by InVS [1,12]. This questionnaire included the
presence or absence of the main general and respiratory symptoms
associated with ILI (fever, asthenia, myalgia, shivers, headache,
cough, rhinitis, pharyngitis, sudden onset) [12].
Detection of H1N1v pandemic influenza A virus and
other respiratory viruses
Total nucleic acid was extracted from 400 mL of Universal
Transport Medium using the EasyMag System (Biome ´rieux,
Marcy l’Etoile, France) in SLS or the EZ1 Advanced XL (Qiagen,
Courtaboeuf, France) in TRS, according to the manufacturers’
instructions (elution volume: 100 mL in SLS or 90 mL in TRS).
Before extraction, 5 ml of an Internal Amplification Control (IAC)
which contained an encephalomyocarditis virus (EMC) RNA
transcript was added into the sample.
Pandemic H1N1v infection was diagnosed by real-time reverse
transcription–PCR (RT-PCR) assay on a 7500 Real Time PCR
System (Applied Biosystems, Foster City, CA) according to the
protocol of the Centers for Disease Control (CDC) [16]. Other
respiratory infections were investigated by a multiplex molecular
assay based on the Multiplex Ligation-dependent Probe-Amplifica-
tion (MLPA) technology (RespiFinder19H, Pathofinder, Maastricht,
The Netherlands) that allows the detection and differentiation of 14
respiratory viruses, including influenza virus A (InfA), influenza virus
B( I n f B ) ,r h i n o v i r u s( R H V ) ,p a r a i n f l u e n z av i r u s e s1t o4( P I V - 1t o
PIV-4), human metapneumovirus (hMPV), adenovirus (ADV),
respiratory syncytial virus A (RSVA), respiratory syncytial virus B
(RSVB) and human coronaviruses 229E, OC43 and NL63 (Cor-
229E, Cor-OC43, Cor-NL63) [17]. The test allows also the detection
of H5N1 influenza A virus and of four bacteria: Chlamydophila
pneumoniae (CP), Mycoplasma pneumoniae (MP), Legionella pneumophila (LP)
and Bordetella pertussis (BP). The amplified MLPA products were
analyzed on an ABI 3100 genetic analyzer (Applied Biosystems,
Foster City, CA). Fragment sizing analysis was performed with the
GeneMarker software (SoftGenetics, LLC, State College, PA).
Further testing for H1N1v was carried out with Simplexa
TM
Influenza A H1N1 (2009) (Focus Diagnostics, Cypress, California)
when the CDC real time RT-PCR assay was negative for H1N1
and the RespiFinder19H assay was positive for Influenza A. If this
latter assay was negative, H3N2 typing was performed as
previously described [18].
Statistical analysis
Data from our study are summarized as frequencies and
percentages for categorical variables. Quantitative variables are
presented as medians, 25th and 75th percentiles. To compare
those variables according to the viral infection status, Fisher tests
Table 1. Number of endonasal swabs sent to SLS and TRS
laboratories for H1N1v detection during weeks 35 through 44.
Week number (2009) Global SLS TRS
35 22 0
36 22 0
37 35 5 30
38 69 12 57
39 64 17 47
40 42 13 29
41 29 9 20
42 28 12 16
43 48 27 21
44 94 44 50
Total 413 143 270
doi:10.1371/journal.pone.0023514.t001
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quantitative variables. To assess the increase of infectious
proportion above the weeks, a Chi square trend test was used.
All tests were two-sided at the 0.05 significance level. Analyses
were performed using R.2.10.1 statistical package (R Development
Core Team, R: A Language and Environment for Statistical
Computing, 2009, Vienna, Austria, http://www.R-project.org).
We choose to not plot the percentage of positive samples for week
35 and week 36. Indeed the small number of tested patients during
those two weeks doesn’t allow us to obtain precise enough
estimations of the prevalence of endonasal swabs positive for
H1N1v or for other respiratory pathogens.
Results
H1N1v detection during weeks 35 through 44
By using CDC reference assay, H1N1v was detected in 66
samples out of 413 (16.6%), more frequently in SLS (38 samples)
than in TRS (28 samples) (p,10
24). Overall, weekly percentage of
H1N1v positive endonasal swabs remained under 10% until week
41 and increase significantly after (PTrend,0.0001) (Figure 1). Rate
of H1N1v detection reached 30% in SLS at week 42 and in TRS
at week 44. Overall, this rate was in agreement with results
provided by the GROG network, showing an earlier start of
H1N1v epidemic in Paris area [7,19].
Detection of other respiratory pathogens during weeks
35 through 44
All 413 nucleic acid extracts were analyzed using the
RespiFinder19H assay (Figure 2). Sixty six patients tested H1N1v
positive with CDC real time RT-PCR assay were confirmed with
the multiplex assay. Thirteen were also co-infected by one or two
other respiratory pathogens (multiple infections) (Figure 2). Three
of the 347 H1N1v negative samples could not be studied with the
multiplex assay because they contained RT-PCR inhibitors (no
amplification of the internal control). Two hundred and fifteen
(62.5%) of the remaining 344 H1N1v negative samples were found
positive for at least one respiratory pathogen (Figure 2). Two
hundred and twelve were positive for non influenza pathogens
(189 single infections and 23 mixed infections with two, three or
four viruses) and three additional single infections by influenza A
were identified in SLS, including two by pandemic H1N1v and
one by seasonal H3N2, as determined after molecular typing (data
not shown).
Overall, 68 patients (16.5%) were then positive for H1N1v, one
for H3N2 and 212 for non influenza pathogens. There were 245
single infections (55 with H1N1v and 190 with other respiratory
pathogens) and 36 mixed infections (13 with H1N1v and 23
without H1N1v) (Figure 2).
Among H1N1v negative single infections, the most prevalent
viruses were rhinovirus (62.6%, 119 patients), followed by
parainfluenza viruses 1 to 4 (24.2%, 46 patients), adenovirus
(5.3%, 10 patients), human coronavirus 229E, OC43 and NL63
(3.2%, 6 patients) and respiratory syncytial virus A and B (2.6%, 5
patients) (Figure 2). In addition, RespiFinder19H assay identified
three patients with bacterial infection, two with Mycoplasma
pneumoniae (one 25 years old female in SLS and one 39 years old
female in TRS) and one with Bordetella pertussis (one 60 years old
male in SLS). No single infection by influenza B, hMPV,
Chlamydophila pneumoniae or Legionella pneumophila was identified
(Figure 2).
In mixed infections, PIV (1 to 4) and RHV were the most
frequent (75% [27/36] and 61.1% [22/36], respectively), followed
by H1N1v (36.1% [13/36]), ADV (27.8% [10/36]) and RSV-B
(5.6% [2/36]) (Figure 2). Co-detection or multi-detection were
very frequent along with adenovirus infection (50% [10/20]), PIV
infection (37.0% [27/73]) including mixed infections with several
types and less frequently with rhinovirus infection (15.6% [22/
141]). The frequency of viral co-infection was slightly higher in
samples positive for H1N1v as compared to samples positive for
other respiratory pathogens, but without significance (19.1% [13/
68] vs. 10.8% [23/213]). RHV was, for instance, the more
frequent co-pathogen in H1N1v positive patients (13.2% [9/68]).
To analyze if viral co-infections occurred more frequently for some
viruses, we carried out a two by two comparisons, that showed a
higher proportion of co-infection only for ADV (p=0.05).
Non-influenza respiratory viruses presented a different epidemic
profile compared to H1N1v. Overall, in both hospitals, weekly
rate of non-H1N1v respiratory viruses whether alone or involved
in co-infection increased between week 37 and 39 (from 51.4% to
81.3%) and then consistently decreased (Figure 3). RHV infections
that represented nearly half of non-H1N1v viral infections (141
Figure 1. Weekly rate of endonasal swabs positive for H1N1v pandemic influenza virus. Percentage of H1N1v positive endonasal swabs
are indicated for each hospital (SLS: open circle, TRS: open square) and for both (plain black triangle and black dotted line). The national weekly rate
from data provided by the GROG network is indicated by a grey dotted line and plain grey circles. The epidemic status of H1N1v was proclaimed in
France by health authorities during the second week of September (black arrow).
doi:10.1371/journal.pone.0023514.g001
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hospitals, emergence of H1N1v cases was associated with a rapid
decline of RHV rate of infection from 50–60% down to less than
20% with a one to two weeks gap between SLS and TRS.
Clinical characteristics
Data on age (Table 2) and gender were available for all 413
patients seen for ILI in both hospitals.
Overall, 124 of the 413 patients (30.0%) were less than 15 years
old (4 in SLS and 120 in TRS) and 281 patients (68.0%) were
under 40 years of age (68 in SLS and 213 in TRS). In SLS, the
median population age was 41 (Interquartile range [IQR]: 28–56)
with 49.7% being males, whereas in TRS, the median population
age was 17 ([IQR=3–34]) with 51.1% being males.
In both institutions, 85.5% (106/124) children younger than 15
years of age were infected by at least one respiratory pathogen
(Table 2). H1N1v infected patients were not significantly younger
than H1N1v non infected patients (27 years old vs. 25 years old,
p=0.80) (Figure 4). However, 70.6% (48/68) of H1N1v cases
were identified in patients under 40 years old (22 in SLS and 26 in
TRS) and no case was observed in patients older than 65 years
(Table 2). PIV infection occurred in very young patients (median
Figure 2. Aetiologies of influenza-like illness. For each pathogen, the number of patients in whom this pathogen was detected (including
single and multiple infections) is indicated in italic at top. The different patterns of single and multiple infections (1 line=1 pattern) are depicted by
the presence of plain black rectangles for relevant pathogens. The total of samples for each pattern is indicated in bold at the end of the line. InfA:
influenza virus A; InfB: influenza virus B; RHV: rhinovirus; PIV-1 to PIV-4: parainfluenza virus 1 to 4; hMPV: human metapneumovirus; ADV: adenovirus;
RSVA and B: respiratory syncytial virus A and B; Cor-229E, Cor-OC43, Cor-NL63: human coronaviruses 229E, OC43 and NL63; CP: Chlamydophila
pneumoniae; MP: Mycoplasma pneumoniae; LP: Legionella pneumophila; BP: Bordetella pertussis.
doi:10.1371/journal.pone.0023514.g002
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24) (Figure 4). The
same observation was made for ADV infection (median age=2.5
vs. 25 for patients without ADV, p=0.006) (Figure 4). Conse-
quently, PIV and ADV were more frequently detected in the
younger population of TRS versus SLS (p,10
24 and p,10
23
respectively). In contrast, although individuals with RHV infection
were slightly younger than individuals without (median age=24 vs.
29 for patients without RHV, p=0.05) (Figure 4), influenza-like
illness associated with RHV was more frequent in SLS than in
TRS (p=0.012). Finally, patients with viral multiple infection
were significantly younger than those with single infection
(median, IDR: 4, 2–18.5 vs. 25, 6–43) and rates of mixed infection
Figure 3. Weekly detection of H1N1v versus non-influenza respiratory viruses in endonasal swabs. Frequencies of weekly detection are
represented in the overall studied population (A), in samples from Saint-Louis hospital (B) or Tours hospital (C), with open circles for non-influenza
respiratory viruses (all non-Inf), plain squares for rhinoviruses (RHV), plain diamonds for parainfluenza viruses (PIV) and open triangles for H1N1v. All
viruses involved in the co-infections were counted individually.
doi:10.1371/journal.pone.0023514.g003
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older ones (19.4% vs. 4.1%, p,0.0001).
At the time of medical attention, 383 (92.7%) standardized
clinical questionnaires were collected out of 413 patients. Four of
them could not be exploited because they were too incomplete. A
review of the 379 workable questionnaires showed that 90.8%
(344/379) of the patients included in this study fulfilled the criteria
of ILI as defined above, and 52.5% had either a severe clinical
presentation or an underlying risk factor of complications (45.9%,
174/379), or were in a suspected cluster of grouped cases (6.6%,
25/379).
Overall, most patients have fever (93.9%) and cough (86.1%)
(Table 3). Other classical clinical signs associated with ILI such as
asthenia, myalgia, shivers, headache, rhinitis or pharyngitis were
less frequent. A sudden onset was also described in 59.2% of cases.
Only 32.5% of the patients had a temperature above 39uC; the
age of these patients ranged from zero to 86 years, with a median
age of 32 years and a mean age of 34 years (data not shown).
In H1N1v infected patients (including single and multiple
infections), the main symptoms were also fever (98.2%) and cough
(89.5%) (Table 3). Similar median temperature was reported in
H1N1v positive and in H1N1v negative patients (39 [IQR=35.5–
41] vs. 38.8 [IQR=37.8–40.4], p=0.68). The proportion of
patients with a temperature above 39uC was not different (H1N1v
positive: 34.3% vs. H1N1v negative: 32.3%, p=0.84) (data not
shown).
We then compared clinical characteristics between patients
positive for H1N1v, patients positive for other respiratory
pathogens and negative for H1N1v and patients without any
detection of respiratory pathogens (as detected with RespiFin-
der19H) (Table 3). There was no difference between the three
groups except for fever, cough, pharyngitis. However for these
latter symptoms, the comparison between patients positive for
H1N1v and those positive for other respiratory pathogens or
between patients positive for H1N1v and those without any
detection of respiratory pathogens, showed no difference except
for pharyngitis, which was less frequent in patients positive for
H1N1v than in patients positive for other respiratory pathogens
(Table 3).
As RHV was the most frequent aetiology in ILI, we also
compared clinical symptoms observed in patients with a single
infection by RHV or by H1N1v (data not shown). There was no
difference except that rhinitis and pharyngitis were significantly
more frequent in RHV infection (62.7% vs. 34.1% [p=0.006] and
39.0% vs. 10.0% [p=0.001], respectively).
Viral multiple infection (including samples with H1N1v) was not
associated with a different clinical presentation. Fever and cough
were observed in over 90% of the patients (90.6% and 90.3%,
respectively), but only 33.3% of these patients had a temperature
above 39uC, which was not different from patients with single viral
infection (28.6%).
Discussion
Our results highlight the high frequency of non-influenza
viruses involved in acute respiratory infections during the epidemic
period of a flu alert as defined by the Re ´seau Sentinelles according
to ILI definition (a sudden fever above 39uC accompanied by
myalgia and respiratory signs). These data extent previous
observations in Europe reporting high prevalence of RHV
infections before seasonal influenza [4,20] or in 2009, before
H1N1v pandemic influenza [1,8,9,11,21]. We confirm that RHV
represent the most frequent aetiology of acute respiratory
Table 2. Age of patients with respiratory samples positive for H1N1v, positive for other respiratory pathogens or negative.
Global H1N1v positive H1N1v negative
Other respiratory pathogens
No respiratory
pathogens
*
Number (%)
(n=143)
Number (%)
(n=68)
Number (%)
(n=213)
Number (%)
(n=132)
Age (in years) ,15 124 (30.0) 16 (23.5) 90 (42.3) 18 (13.6)
15–39 157 (38.0) 32 (47.1) 68 (31.9) 57 (43.2)
40–64 103 (25.0) 20 (29.4) 34 (16.0) 49 (37.1)
$ 65 29 (7.0) 0 (0.0) 21 (9.8) 8 (6.1)
*These data include the 3 patients whose respiratory samples could not be studied with the multiplex assay because of RT-PCR inhibitors.
doi:10.1371/journal.pone.0023514.t002
Figure 4. Association between age and respiratory viral
infections. For each distribution, the horizontal lines represent the
10th, 25th, 50th (median), 75th, and 90th percentiles. Comparison used
Wilcoxon’s test. H1N1v: H1N1v pandemic influenza virus; PIV: parain-
fluenza virus; ADV: adenovirus; RHV: rhinovirus.
doi:10.1371/journal.pone.0023514.g004
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represent more than 50% of cases. We show that other viral
infections than influenza and RHV may represent up to 30% of
aetiologies. We observed differences between the two hospitals,
with a higher frequency of parainfluenza and ADV infections in
Tours in contrast with a higher frequency of RHV in Paris, likely
explained by the higher proportion of paediatric samples collected
in Tours. However, despite the distance between the two
institutions (about 250 km) and differences between the two
populations, both presented similar patterns of high frequency of
non-influenza viruses in acute respiratory infections before the flu
epidemic wave and a decline when influenza reached epidemic
levels.
In the two cities, high frequencies of RHV were seen at the
same level with a likely different evolution speed, with sudden
increase and decrease in SLS and more progressive variation in
TRS. In both institutions, there was a decrease in the proportion
and number of RHV diagnoses roughly in parallel with the
increase of influenza diagnoses. Indeed, H1N1v exceeds 20% of
positive detection’s rate only when RHV dropped under 40%.
These data are thus consistent with negative interaction of the two
epidemics at the population level. It was previously hypothesised
that RHV epidemic could interfere with the spread of pandemic
influenza [20,21,22]. Few in vitro data support this hypothesis. It
has been reported that interferon and other cytokines production
by RHV infected cells induced a refractory state to virus infection
Table 3. Clinical characteristics of patients with respiratory samples positive for H1N1v, positive for other respiratory pathogens or
negative.
Global H1N1v positive H1N1v negative pI {{ p" {{ p** {{
Other respiratory
pathogens
No respiratory
pathogens
1
Number (%)
(n=413) Number (%) (n=68) Number (%) (n=213) Number (%) (n=132)
Fever w/* 354 (93.9) 56 (98.2) 177 (90.8) 121 (96.8) 0.036 0.08 1
w/o
{ 23 (6.1) 1 (1.8) 18 (9.2) 4 (3.2)
N/A
{ 26 11 18 7
Asthenia w/ 140 (57.6) 25 (50.0) 60 (57.1) 55 (62.5) 0.37
w/o 103 (42.4) 25 (50.0) 45 (42.9) 33 (37.5)
NA 160 18 108 44
Myalgia w/ 195 (58.4) 28 (52.8) 98 (59.0) 69 (60.0) 0.68
w/o 139 (41.6) 25 (47.2) 68 (41.0) 46 (40.0)
N/A 69 15 47 17
Shivers w/ 72 (32.0) 16 (31.4) 28 (30.8) 28 (33.7) 0.93
w/o 153 (68.0) 35 (68.6) 63 (69.2) 55 (66.3)
N/A 178 17 122 49
Headache w/ 95 (40.8) 17 (33.3) 40 (42.1) 38 (43.7) 0.48
w/o 138 (59.3) 34 (66.7) 55 (57.9) 49 (56.3)
N/A 170 17 118 45
Cough w/ 315 (86.1) 51 (89.5) 173 (90.1) 91 (77.8) 0.01 1 0.09
w/o 51 (16.9) 6 (10.5) 19 (9.9) 26 (22.2)
N/A 37 11 21 15
Rhinitis w/ 103 (42.9) 19 (37.3) 53 (52.0) 31 (35.6) 0.053
w/o 137 (57.1) 32 (62.7) 49 (48.0) 56 (64.4)
NA 163 17 111 45
Pharyngitis w5 4 (24.1) 5 (10.0) 31 (34.4) 18 (21.4) 0.003 0.001 0.10
w/o 170 (75.9) 45 (90.0) 59 (65.6) 66 (78.6)
N/A 179 18 123 48
Sudden onset w/ 141 (59.2) 27 (54.0) 58 (57.4) 56 (64.4) 0.42
w/o 97 (40.8) 23 (46.0) 43 (42.6) 31 (35.6)
N/A 165 18 112 45
*w/: presence of the clinical sign,
{w/o: absence of the clinical sign,
{N/A: not available.
1These data include the three patients whose respiratory samples could not be studied with the multiplex assay because of RT-PCR inhibitors.
IComparison between the three groups of patients (with respiratory samples respectively positive for H1N1v, positive for other respiratory pathogens or negative). If p
value is significant (,0.05), patients positive for H1N1v are compared with patients positive for other respiratory pathogens
(") and with patients without any detection
of respiratory pathogens
(**).
{{Significant p values (,0.05) are indicated in bold.
doi:10.1371/journal.pone.0023514.t003
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vitro and in vivo such negative interactions and if viral interference
are really translated to a population level. Analysis of rhinovirus
and influenza epidemics in previous years should also help to
determine if similar interferences were observed with seasonal
influenza and to elaborate modelling and prediction of the spread
of influenza according to respiratory viruses’ circulation. System-
atic extensive screening of respiratory viruses at a national level
should be implemented for this purpose.
Very few RSV infections were observed in contrast to usual
epidemiology which was characterized the last four past years by a
start of epidemics in weeks 44–45 [1]. It has been confirmed by
other laboratories and the French InVS that the 2009–10 RSV
epidemic was delayed and had a lower impact compared with the
previous winter season [1,24]. Delayed and reduced RSV spread
may be due to viral interference between RSV and influenza.
Another possible explanation is better prevention behaviour about
respiratory infections as recommended by a national campaign
including recommendations for hands washing after sneezing and
the use of mask [1].
Influenza infections were mainly detected in patient under 40
years old and no case was found in patients older than 65. These
results corroborate previous data suggesting that past seasonal
H1N1 infections or vaccination may give partial crossed
protection [10,13,25]. We have previously shown that the
neutralizing titers against pandemic H1N1v virus correlate
significantly with neutralizing titers against a seasonal H1N1
virus, and that the H1N1v pandemic influenza virus neutralizing
titer was significantly higher in subjects who had recently been
inoculated by a seasonal trivalent influenza vaccine [26].
Viral co-infections were predominantly seen in paediatric
patients, as previously described [4,27,28,29], both in influenza
and non-influenza cases at a similar rate. No evidence of more
pronounced respiratory impact was seen in these patients.
Our results showed the lack of specific clinical signs associated
with proven H1N1v infections. Clinical characteristics did not
differ between influenza infections or other viral infections. In
particular, the proportion of patients with fever above 39uC was
not higher in H1N1v positive patients. In addition, the patients
without any evidence of respiratory viral infections did not have
different symptoms. These patients may have been infected with
other virus not included in the multiplex assay (human Bocavirus,
coronavirus HKU1) [9,10,11] or were seen too late at the time of
viral shedding was cleared [30]. However, to determine how
specific the symptoms are for influenza would require to assess also
the distribution of respiratory pathogens (H1N1v and other
respiratory viruses) and related symptoms in patients presented
at the emergency departments in SLS and TRS with respiratory
syndromes, but not tested for H1N1v. In addition, despite some
underlying conditions that were associated with complications not
previously observed in seasonal influenza, most illnesses caused by
the H1N1v virus were acute and self-limited [13,31]. The higher
proportion of non influenza viruses reported in ILI in 2009 was
thus most likely a consequence of more frequent visits to a doctor
for respiratory tract infections than usually observed for fear of the
flu pandemic. The general lack of difference in symptoms in the
particular context of H1N1v pandemic has therefore to be
considered with caution and does not rule out that more significant
differences may arise in future influenza epidemics with other
influenza viruses. Our data confirm that it may be virtually
impossible to recognize symptoms heralding H1N1v infections and
virological data should be helpful along with clinical reports to
monitor influenza epidemic [10].
Molecular multiplex detection has recently emerged as a potent
diagnostic tool to determine acute respiratory infections’ aetiolo-
gies [11,32,33]. These data show that sensitive molecular
multiplex detection of respiratory viruses is feasible and efficient
for the detection of virus involved in acute respiratory infections
and provides insights into their epidemic profile. Our results
confirm the performance of RespiFinder19H assay to detecting
respiratory viruses in the general population as recently shown in
transplant patients with ILI [34]. RespiFinder19H confirmed all
H1N1 infections detected by the CDC reference assay and was
able to identify two additional H1N1 cases suggesting a high
sensitivity of this multiplex assay to detect influenza A infections.
In conclusion, our results highlight that successive and mixed
outbreaks of respiratory viral infections may affect influenza
epidemiology and can lead to misinterpret the early development
of a flu epidemic. Rapid diagnostic screening of a large panel of
respiratory pathogens may be critical to define and survey the
epidemic situation and to provide critical information for patient
management.
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